Patent 11547756 was granted and assigned to MedImmune on January, 2023 by the United States Patent and Trademark Office.
Provided herein are methods for treating, reducing or preventing influenza A virus infection in a patient, as well as compositions and articles of manufacture for treating, reducing or preventing influenza A virus infection in a patient.